Trial intelligence / Profile preview

Folic Acid and Vitamin B Complex in HCV Patients Treated with PEG-IFN/RBV

NCT02150291Phase 4Unknown

Sponsor
The British University in Egypt
Start
May 2014
Primary completion
May 2015
Modality
Implantable Devices, Transdermal Patches, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of folic acid, Neurovit Forte in hepatitis C (HCV), sponsored by The British University in Egypt. Status: unknown.

02

Drugs

folic acidNeurovit Forte
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT02150291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02150291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call